The patient subsequently underwent CT-guided percutaneous lung biopsy of pulmonary lesion, which revealed adenocarcinoma with EGFR exon 19 deletion without EGFR T790M and other resistant mutations. The gene discussed is EGFR; the disease is adenocarcinoma.